Efficacy of sclerotherapy with sodium tetradecyl sulphate in the treatment of pyogenic granuloma (original) (raw)
Related papers
Pyogenic Granuloma - A Simple Treatment Approach with Sclerotherapy
2021
Pyogenic granuloma (PG) is a benign exophytic vascular tumor, which is actually a reactive inflammatory mass of blood vessels with few fibroblasts within the mucosa or skin, was first reported by Hullihen in 1844. Variety of treatment options such as surgical excision, laser treatment, electrodessication, chemical cautery, cryosurgery, intralesional steroid injection etc. are available, but many a times, recurrence has also been reported. Sclerotherapy is defined as the "targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a "sclerosant". It offers an alternative to conventional methods like surgery, lasers, radio frequency ablation and electrodesiccation procedure with success and less chance of recurrences. Herein, we present a case of 22 years old female with a clinical diagnosis of PG, treated with intralesional 0.2 ml of 3% sodium tetradecyl sulfate (STS). The lesion healed completely at the patient's 3 rd visit and recurrence was not reported till the patient was followed up for one year.
Treatment of Pyogenic Granuloma with a Sclerosing Agent
Dermatologic Surgery, 2001
background. Pyogenic granulomas have been treated by cryosurgery, curettage, electrodesiccation, chemical cauterization, and laser surgery. The therapeutic effects of these conservative treatments are limited, however. objective. In this study, the efficacy of a sclerosing agent (monoethanolamine oleate) was evaluated for the treatment of pyogenic granuloma. methods. Pyogenic granuloma was treated by local injection of the monoethanolamine oleate solution in nine patients who were from 1 to 57 years of age (median 18 years). The treatment effect was determined by physical examination. results. All lesions were removed completely with no recurrence, and scars were inconspicuous in all cases. Complications occurred in only one patient who complained of pain due to an avoidable injection of excess solution. conclusion. Sclerotherapy with monoethanolamine oleate is effective in the treatment of pyogenic granuloma and offers an alternative to conventional methods in cases for which conservative treatment is preferable.
Sclerotherapy: a bloodless approach in treatment of pyogenic granuloma in children
International Journal of Dermatology, 2020
Pyogenic granuloma (PG) is a common, acquired tumor-like growth occurring on skin/mucous membranes. It is prevalent in the pediatric age group. It is benign in nature and is caused by chronic low grade trauma. It presents as pink to red elevated pedunculated or sessile mass. There are various treatment modalities including surgery, cryotherapy, laser, electrocautery, etc. However, the therapeutic effects are limited with high recurrence rates. The use of sclerotherapy for the treatment of pyogenic granuloma in children is not commonly reported. We present a case of PG on the scalp successfully treated with intralesional injection of sodium tetradecyl sulfate.
Indian Journal of Otolaryngology and Head & Neck Surgery, 2020
Sclerotherapy is a targeted elimination of small vessels, varicose veins, and vascular anomalies by the injection of a sclerosant. Sclerotherapy aims to damage the vessel wall and transform it into fibrous tissue. The present study was conducted to evaluate the efficacy of a sclerosing agent 3% polidocanol in the treatment of vascular lesions and pyogenic granuloma. The solution was injected intralesionally at multiple sites and was repeated after an interval of 2 weeks. The treatment effect was determined by clinical examination. Sclerotherapy with 3% polidocanol is effective in the treatment of vascular lesions and pyogenic granuloma. This treatment modality offers an alternative to conventional methods such as surgical excision, laser therapy, cryotherapy, steroid therapy, etc., in cases where conservative treatment is preferable. The advantage is that it causes minimal discomfort, negligible blood loss, less cumbersome, and above all is economical. There is no requirement of local anesthesia or postoperative dressings or any specific care. The patient can resume his daily activities immediately.
Outcome of sclerosing agent for managing the oral pyogenic granuloma
The Professional Medical Journal
Objectives: Outcome sclerosing agent for managing the oral pyogenic granulomain terms of post-operative pain, post-operative healing and post-operative infection. Study Design: Cross-section study. Setting: Department of Oral & Maxillofacial Surgery, Institute of Dentistry, Liaquat University of Medical & Health Sciences Jamshoro / Hyderabad. Period: October 2018 to March 2019. Material & Methods: Patients with oral pyogenic granuloma and willing to contribute in study were included. Sclerosing agent (ethanolamine oleate) was taken in 3cc disposable syringe and injected in each lesion once a week and repeated according to need. Patients were fooled for 1 to 3 weeks. Outcome was assessed in terms of post-operative pain, post-operative healing and post-operative infection. Data was recorded in proforma. Results: Total seventy four patients were included; their mean age was 40.67+4.99 years. Males were in majority 59.5%. On 1st week 32 showed mild pain which was markedly decreased on 2...
Treatment of pyogenic granuloma with b blocker
الرحيم الرحمن هللا بسم الرحمن ۞ علم القرآن ۞ خلق االنسان ۞ علمه البيان سورة الرحمن االية 1-4 Acknowledgments First and foremost, thanks to ALLAH, to whom I relate my success in achieving any work in my life. I am grateful to Prof Dr. Abd El-Aziz Ibrahim El-Taweel, Professor of Dermatology and Andrology, Faculty of Medicine, Benha University, for his great help, kind supervision, good plan and facilitation for performance of this work. He provided me a lot of time and facilities to make this work possible. It was a great honor to work under his supervision. I would like to express my thanks and gratitude to
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy
Dermatology online journal
A pyogenic granuloma (PG) is a rapidly growing benign vascular tumor that can be found on the skin or subcutaneous tissue. While some pyogenic granulomas may resolve spontaneously, most have a tendency to bleed easily and require treatment. Current therapeutic modalities include topical imiquimod, cryotherapy, electrodessication, curettage, excision, laser therapy, sclerotherapy, and microembolization. We report a recalcitrant case of chronic pyogenic granuloma occurring on the scalp of a healthy young male which was unresponsive to conventional surgical and non-surgical modalities. Ultimately, aggressive laser therapy, intralesional triamcinolone acetonide injections, and topical timolol application led to complete resolution and healing.